284 related articles for article (PubMed ID: 29917184)
1. Long noncoding RNA SNHG5 is up-regulated and serves as a potential prognostic biomarker in acute myeloid leukemia.
Li J; Sun CK
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3342-3347. PubMed ID: 29917184
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.
Wang Y; Li Y; Song HQ; Sun GW
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7364-7370. PubMed ID: 30468482
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA SNHG5 regulates chemotherapy resistance through the miR-32/DNAJB9 axis in acute myeloid leukemia.
Wang D; Zeng T; Lin Z; Yan L; Wang F; Tang L; Wang L; Tang D; Chen P; Yang M
Biomed Pharmacother; 2020 Mar; 123():109802. PubMed ID: 31884339
[TBL] [Abstract][Full Text] [Related]
4. LncRNA SNHG5 regulates SOX4 expression through competitive binding to miR-489-3p in acute myeloid leukemia.
Ying X; Zhang W; Fang M; Wang C; Han L; Yang C
Inflamm Res; 2020 Jun; 69(6):607-618. PubMed ID: 32266420
[TBL] [Abstract][Full Text] [Related]
5. LINC00649 underexpression is an adverse prognostic marker in acute myeloid leukemia.
Guo C; Gao YY; Ju QQ; Zhang CX; Gong M; Li ZL
BMC Cancer; 2020 Sep; 20(1):841. PubMed ID: 32883226
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.
Ma L; Kuai WX; Sun XZ; Lu XC; Yuan YF
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7867-7876. PubMed ID: 30536332
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
8. The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature.
Díaz-Beyá M; Brunet S; Nomdedéu J; Pratcorona M; Cordeiro A; Gallardo D; Escoda L; Tormo M; Heras I; Ribera JM; Duarte R; de Llano MP; Bargay J; Sampol A; Nomdedeu M; Risueño RM; Hoyos M; Sierra J; Monzo M; Navarro A; Esteve J;
Oncotarget; 2015 Oct; 6(31):31613-27. PubMed ID: 26436590
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients.
Tsai CH; Yao CY; Tien FM; Tang JL; Kuo YY; Chiu YC; Lin CC; Tseng MH; Peng YL; Liu MC; Liu CW; Yao M; Lin LI; Chou WC; Chen CY; Hou HA; Tien HF
EBioMedicine; 2019 Feb; 40():240-250. PubMed ID: 30662003
[TBL] [Abstract][Full Text] [Related]
10. Serum MicroRNA-370 as a potential diagnostic and prognostic biomarker for pediatric acute myeloid leukemia.
Lin X; Wang Z; Wang Y; Feng W
Int J Clin Exp Pathol; 2015; 8(11):14658-66. PubMed ID: 26823789
[TBL] [Abstract][Full Text] [Related]
11. Long non‑coding RNA LINC00460 serves as a potential biomarker and oncogene via regulation of the miR‑320b/PBX3 axis in acute myeloid leukemia.
Zhuang Q; Jin Z; Zheng X; Jin T; Xiang L
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846790
[TBL] [Abstract][Full Text] [Related]
12. A three‑lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.
Wang F; Tian X; Zhou J; Wang G; Yu W; Li Z; Fan Z; Zhang W; Liang A
Mol Med Rep; 2018 Aug; 18(2):1473-1484. PubMed ID: 29901168
[TBL] [Abstract][Full Text] [Related]
13. Identification of seven novel ferroptosis-related long non-coding RNA signatures as a diagnostic biomarker for acute myeloid leukemia.
Zheng Z; Wu W; Lin Z; Liu S; Chen Q; Jiang X; Xue Y; Lin D
BMC Med Genomics; 2021 Sep; 14(1):236. PubMed ID: 34579730
[TBL] [Abstract][Full Text] [Related]
14. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
[TBL] [Abstract][Full Text] [Related]
15. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.
Pan JQ; Zhang YQ; Wang JH; Xu P; Wang W
Int J Mol Med; 2017 Mar; 39(3):663-671. PubMed ID: 28204819
[TBL] [Abstract][Full Text] [Related]
16. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.
Wang Y; Zhou Q; Ma JJ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):763-770. PubMed ID: 29461608
[TBL] [Abstract][Full Text] [Related]
17. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
Jiang Z; Yu Q; Luo X
J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens.
Luo W; Yu H; Zou X; Ni X; Wei J
Cancer Biomark; 2018; 23(4):485-494. PubMed ID: 30347595
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA Maternally Expressed Gene 3 Is Downregulated, and Its Insufficiency Correlates With Poor-Risk Stratification, Worse Treatment Response, as Well as Unfavorable Survival Data in Patients With Acute Myeloid Leukemia.
He C; Wang X; Luo J; Ma Y; Yang Z
Technol Cancer Res Treat; 2020; 19():1533033820945815. PubMed ID: 32720591
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG5 upregulation induced by YY1 contributes to angiogenesis via miR-26b/CTGF/VEGFA axis in acute myelogenous leukemia.
Li ZJ; Cheng J; Song Y; Li HH; Zheng JF
Lab Invest; 2021 Mar; 101(3):341-352. PubMed ID: 33318617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]